1. Home
  2. NMFC vs LXRX Comparison

NMFC vs LXRX Comparison

Compare NMFC & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Mountain Finance Corporation

NMFC

New Mountain Finance Corporation

HOLD

Current Price

$7.94

Market Cap

796.4M

Sector

Finance

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.16

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMFC
LXRX
Founded
2010
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
796.4M
703.3M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
NMFC
LXRX
Price
$7.94
$2.16
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$8.63
$4.15
AVG Volume (30 Days)
554.1K
2.9M
Earning Date
05-04-2026
05-01-2026
Dividend Yield
15.27%
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.51
N/A
Revenue Growth
N/A
60.24
52 Week Low
$7.47
$0.62
52 Week High
$11.04
$2.53

Technical Indicators

Market Signals
Indicator
NMFC
LXRX
Relative Strength Index (RSI) 41.59 59.11
Support Level $7.50 $1.14
Resistance Level $8.65 $2.53
Average True Range (ATR) 0.20 0.18
MACD -0.04 0.01
Stochastic Oscillator 8.76 63.37

Price Performance

Historical Comparison
NMFC
LXRX

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: